The metropolitan Detroit area is home to a population that is ethnically and culturally diverse, and the Population Studies and Prevention program brings together faculty with a variety of scholarly interests whose research is based on this diversity. The Program has developed three major themes: 1) Cancer Etiology and Prognosis, with a research emphasis on population-based studies of cancer etiology and race/ethnicity related health disparities; 2) Prevention, with a research emphasis on studies designed to prevent and/or control the development of cancer within this population; and 3) Communication and Behavioral Oncology, with a research emphasis on understanding the role of communication in determining how best to change and improve health behavior. Our population-based studies focus on the interface between genetic and environmental exposures and their roles in the subsequent development of cancer and survival from this disease. These studies aim to define the contribution of familial risk, describe patterns of inheritance and discover susceptibility genes for cancer. Modification of risk by diet, smoking and other environmental factors is also explored. Our major research emphasis in prevention is on understanding the role, at a molecular level, that nutrition plays in the prevention of cancer. Research focuses on the preventive effects of soy isoflavones, lycopene, folic acid, tea polyphenols, zinc, increased fruits and vegetables, and a low fat diet in a variety of cancers. The effects of these interventions on molecular targets such as NF-kB, AKT, EGFR and IL-2 are currently under investigation, with basic science work translated into chemoprevention trials when appropriate. As we identify risk factors for disease, behavioral intervention strategies and new chemopreventive agents, work in the Communication and Behavioral Oncology area emphasizes how to most effectively communicate these findings to protect the health of our diverse population.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA022453-25
Application #
7310827
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2005-12-01
Budget End
2006-11-30
Support Year
25
Fiscal Year
2006
Total Cost
$19,991
Indirect Cost
Name
Wayne State University
Department
Type
DUNS #
001962224
City
Detroit
State
MI
Country
United States
Zip Code
48202
Herroon, Mackenzie K; Rajagurubandara, Erandi; Diedrich, Jonathan D et al. (2018) Adipocyte-activated oxidative and ER stress pathways promote tumor survival in bone via upregulation of Heme Oxygenase 1 and Survivin. Sci Rep 8:40
Colacino, Justin A; Azizi, Ebrahim; Brooks, Michael D et al. (2018) Heterogeneity of Human Breast Stem and Progenitor Cells as Revealed by Transcriptional Profiling. Stem Cell Reports 10:1596-1609
Blocker, Stephanie J; Shields, Anthony F (2018) Imaging of Nanoparticle Distribution to Assess Treatments That Alter Delivery. Mol Imaging Biol 20:340-351
Guastella, Anthony R; Michelhaugh, Sharon K; Klinger, Neil V et al. (2018) Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors. J Neurooncol 139:239-249
Li, Feng; Wang, Yongli; Li, Dapeng et al. (2018) Perspectives on the recent developments with green tea polyphenols in drug discovery. Expert Opin Drug Discov 13:643-660
Ramseyer, Vanesa D; Kimler, Victoria A; Granneman, James G (2018) Vacuolar protein sorting 13C is a novel lipid droplet protein that inhibits lipolysis in brown adipocytes. Mol Metab 7:57-70
Healy, Mark A; Morris, Arden M; Abrahamse, Paul et al. (2018) The accuracy of chemotherapy ascertainment among colorectal cancer patients in the surveillance, epidemiology, and end results registry program. BMC Cancer 18:481
Lacher, Sarah E; Alazizi, Adnan; Wang, Xuting et al. (2018) A hypermorphic antioxidant response element is associated with increased MS4A6A expression and Alzheimer's disease. Redox Biol 14:686-693
Alsaab, Hashem O; Sau, Samaresh; Alzhrani, Rami M et al. (2018) Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophages. Biomaterials 183:280-294
Chammaa, May; Malysa, Agnes; Redondo, Carlos et al. (2018) RUMI is a novel negative prognostic marker and therapeutic target in non-small-cell lung cancer. J Cell Physiol 233:9548-9562

Showing the most recent 10 out of 826 publications